4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
China SXT Pharmaceuticals, Inc. (SXTC) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Taizhou, China with about 56 employees. Its market capitalization is roughly $97 million. In the fiscal year ended 2026-03-31, SXTC reported $1M in revenue and ($6M) in net income.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
Interactive charts & full statements → Open the SXTC valuation workbench →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $2M | $2M | $2M | — |
| Gross Profit | $0M | $0M | $1M | $0M | — |
| Operating Income (EBIT) | ($7M) | ($3M) | ($2M) | ($6M) | — |
| Net Income | ($6M) | ($3M) | ($3M) | ($6M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | $35M | $22M | $23M | $30M | — |
| Total Liabilities | $5M | $6M | $9M | $15M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SXTC viewer.
About TickerBase · Data methodology & sources